CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Simulations Plus Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Simulations Plus Inc
42505 10th Street West
Phone: (661) 723-7723p:661 723-7723 LANCASTER, CA  93534-7059  United States Ticker: SLPSLP
Business Summary
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. It operates through two segments: software and services. It offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
8/31/20248/31/2024YesYes--Yes

Industries
SIC Code Description
7373 Computer integrated systems design
7372 Prepackaged software
7371 Computer programming services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Walter S.Woltosz 78 6/26/2018 7/1/1996
Chief Executive Officer Shawn M.O'Connor 64 6/26/2018 6/26/2018
Chief Financial Officer, Chief Operating Officer, Secretary WilliamFrederick 61 1/3/2024 12/1/2020
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Cognigen Corporation 1780 Wehrle Drive Buffalo NY United States

Business Names
Business Name
Caravel Group Communications, LLC
Eclipse Meeting Productions, LLC
Pro-ficiency, LLC
Simulations Plus International, Inc.
SLP
Zuma Clinical Communications, LLC

General Information
Number of Employees: 243 (As of 8/31/2024)
Outstanding Shares: 20,067,184 (As of 10/18/2024)
Shareholders: 37
Stock Exchange: NASD
Federal Tax Id: 954595609
Fax Number: (661) 723-5524
Email Address: info@simulations-plus.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024